| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 02/12/2004 | US20040029876 Acylamino cyclopropane derivatives |
| 02/12/2004 | US20040029875 Novel aminotriazolone compounds, method for preparing same and pharmaceutical compositions containing same |
| 02/12/2004 | US20040029874 Anticoagulants; cardiovascular disorders |
| 02/12/2004 | US20040029863 Carboxylic acid substituted heterocycles, derivatives thereof and methods of use |
| 02/12/2004 | US20040029861 Using compound containing pyridine ring |
| 02/12/2004 | US20040029859 Compounds useful in therapy |
| 02/12/2004 | US20040029857 Anticancer agents; central nervous system disorders; antiinflamamtory agents |
| 02/12/2004 | US20040028732 Rapidly-decomposing administrable form for releasing active ingredients in the oral cavity or in bodily cavities |
| 02/12/2004 | US20040028673 Compositions and methods for prevention and treatment of amyloid-beta peptide-related disorders |
| 02/12/2004 | DE10234617A1 New (S)-pantoprazole magnesium hydrates are acid secretion inhibitors useful for the treatment of gastrointestinal disorders |
| 02/12/2004 | DE10233817A1 Substituierte Diarylheterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Substituted Diarylheterocyclen, processes for their preparation and their use as medicaments |
| 02/12/2004 | DE10233366A1 In 6-Stellung substituierte Indolinonderivate, ihre Herstellung und ihre Verwendung als Arzneimittel In the 6-position substituted indolinone derivatives, their preparation and their use as medicaments |
| 02/12/2004 | CA2494593A1 4-trifluormethylpyrazolyl-substituted pyridines and pyrimidines |
| 02/12/2004 | CA2494518A1 Novel crystalline forms of gatifloxacin |
| 02/12/2004 | CA2494288A1 Novel salt and polymorphs of desloratadine hemifumarate |
| 02/12/2004 | CA2494139A1 Biaryl compounds having anti-infective activity |
| 02/12/2004 | CA2493982A1 Method for producing highly pure hydroxy indolyl glyoxylic acid amides |
| 02/12/2004 | CA2493749A1 4-trifluoromethylpyrazolyl substituted pyridines and pyrimidines |
| 02/12/2004 | CA2493618A1 Nitrosated proton pump inhibitors, compositions and methods of use |
| 02/12/2004 | CA2493253A1 Compounds useful for the treatment of diseases responsive to antiangiogenetic therapy |
| 02/12/2004 | CA2492830A1 Pyrrolidine derivatives as tryptase inhibitors |
| 02/11/2004 | EP1388552A1 Water-soluble or water-dispersible cationic polyepoxy compounds |
| 02/11/2004 | EP1388535A1 Acylated arylcycloalkylamines and their use as pharmaceuticals |
| 02/11/2004 | EP1388342A1 Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals |
| 02/11/2004 | EP1388341A1 Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals |
| 02/11/2004 | EP1387849A1 Polymerisation catalyst |
| 02/11/2004 | EP1387845A2 PROCESSES FOR THE SYNTHESIS OF DERIVATIVES OF 2,3-DIHYDRO-1,4-DIOXINO-(2,3-f) QUINOLINE |
| 02/11/2004 | EP1387840A1 3,5-diamino-1,2,4-triazoles as kinase inhibitors |
| 02/11/2004 | EP1387839A1 Process for the production of quinazolines |
| 02/11/2004 | EP1387838A1 Cyanoanthranilamide derivatives and the use thereof as medicaments |
| 02/11/2004 | EP1387837A1 Novel azole or triazole derivatives, method for preparing same and use thereof as antifungal medicines |
| 02/11/2004 | EP1387836A1 Phthalazine derivatives with angiogenesis inhibiting activity |
| 02/11/2004 | EP1387830A1 Novel 4-anilinoquinoline-3-carboxamides |
| 02/11/2004 | EP1387688A2 Benzazepinone alpha v integrin receptor antagonists |
| 02/11/2004 | EP1387682A1 Treatment of adhd |
| 02/11/2004 | EP1387679A1 Sulfonamides |
| 02/11/2004 | EP1387612A1 Pyridinyl fused bicyclic amide as fungicides |
| 02/11/2004 | EP1299356B1 Novel compounds |
| 02/11/2004 | EP1240157B1 Substituted n-benzyl-indol-3-yl glyoxylic acid derivatives having an anti-tumoral effect |
| 02/11/2004 | EP1216239B1 Piperazine derivatives as 5-ht1b antagonists |
| 02/11/2004 | EP1183251B1 Indolylpiperidine derivatives as antihistaminic and antiallergic agents |
| 02/11/2004 | EP1042300B1 Phthalazine derivatives useful as phosphodiesterase 4 inhibitors |
| 02/11/2004 | EP1032561B1 Substituted oximes as neurokinin antagonists |
| 02/11/2004 | EP1020462B1 Heterocyclic compounds and antitumor agent containing the same as active ingredient |
| 02/11/2004 | EP1006110B1 Derivatives of acyl-piperazinil-pyrimidins, preparation thereof and application as medicaments |
| 02/11/2004 | EP0936912B1 Inhibitors of cysteine protease |
| 02/11/2004 | CN1474815A 4-amino-quinazolines |
| 02/11/2004 | CN1474810A Substituted urea neuropeptide YY5 antagonists |
| 02/11/2004 | CN1474809A Cyanopyrolidine derivatives |
| 02/11/2004 | CN1474803A Novel amide derivatives and medicinal use thereof |
| 02/11/2004 | CN1474702A Oral pharmaceutical composition containing a block copolymer |
| 02/11/2004 | CN1474652A Substituted 4,5-dihydro-1,2,4-triazin -6-ones, 1,2,4-triazin-6-ones, and their use as fungicides and insecticides |
| 02/11/2004 | CN1473831A Process for preparing pyrazolo (4,3-d) pyrimidine-7-ketone and its intermediate |
| 02/11/2004 | CN1473827A 3-position substituted quinolone derivativers and its use in pharmacy |
| 02/11/2004 | CN1137890C 8-alkoxyquinolone carboxylic acid with excellent stability and process for producing same |
| 02/11/2004 | CN1137886C Novel 2,3-dioxo-1,2,3,4-tetrahydro-quinoyxalinyl derivatives |
| 02/11/2004 | CN1137884C Indazole compounds and pharmaceutical compositions for inhibiting protein kinases and methods for their use |
| 02/11/2004 | CN1137686C Remedies for spinal canal stenosis |
| 02/10/2004 | US6689886 Treatment of inflammation and other immune disorders |
| 02/10/2004 | US6689883 Substituted pyridines and pyridazines with angiogenesis inhibiting activity |
| 02/10/2004 | US6689806 Indolinone compounds as kinase inhibitors |
| 02/10/2004 | US6689801 Certain heteroaryl substituted thiol inhibitors of endothelin-converting enzyme |
| 02/10/2004 | US6689794 Aromatic sulfone hydroxamates and their use as protease inhibitors |
| 02/10/2004 | US6689789 Antitumor, anticancer agents |
| 02/10/2004 | US6689787 Method of using an integrin antagonist and radiation therapy as combination therapy in the treatment of neoplasia |
| 02/10/2004 | US6689786 Sulfonylurea, sulfonylthiourea, sulfonylguanidine, sulfonylcyanoguanidine and acylsulfonamide derivatives; antithrombotics |
| 02/10/2004 | US6689783 Aryl oxime-piperazines useful as CCR5 antagonists |
| 02/10/2004 | US6689782 3-piperazinyl-2-diarylurea-quinazolinone derivatives; potentiators of antifungal agents |
| 02/10/2004 | US6689780 Heteroroaromatic amides as inhibitor of factor Xa |
| 02/10/2004 | US6689772 Antineoplastic agents; osteoporosis; polycystic kidney disease; antiviral agents |
| 02/10/2004 | US6689771 Amide derivatives as inhibitors of matrix metalloproteinases, TNF-α, and aggrecanase |
| 02/10/2004 | US6689765 Viricides; antiinflammatory agents |
| 02/10/2004 | US6689761 Compound j, nucleoside analog hiv reverse transcriptase inhibitor 3tc and azt |
| 02/10/2004 | US6689754 Heterocyclic glycyl β-alanine derivatives |
| 02/10/2004 | US6689337 Vitronectin receptor antagonist pharmaceuticals |
| 02/10/2004 | CA2297134C A novel process for preparing intermediates or inhibitors of enkephalinase and angiotensin converting enzyme and intermediates thereof |
| 02/10/2004 | CA2293709C Synthesis of intermediates useful in preparing bromo-substituted tricyclic compounds |
| 02/10/2004 | CA2223551C Benzimidazole compounds |
| 02/10/2004 | CA2180301C Substituted dihydrodibenzo/b,f/azepines, method of their preparation, their use in the treatment of some central nervous system disorders, and pharmaceutical compositions containing them |
| 02/05/2004 | WO2004011457A1 1-phenylpiperidin-3-one derivatives and processes for the preparation thereof |
| 02/05/2004 | WO2004011456A1 Protein tyrosine kinase inhibitors |
| 02/05/2004 | WO2004011455A1 Preparation of lansoprazole and related compounds |
| 02/05/2004 | WO2004011454A2 Quinolyl propyl piperidine derivatives, preparation method and intermediates and compositions containing same |
| 02/05/2004 | WO2004011453A2 Method for preparing 3-halo-4,5-dihydro-1h-pyrazoles |
| 02/05/2004 | WO2004011447A2 Method for preparing fused oxazinones from ortho-amino aromatic carboxylic acid and a carboxylic acid in the presence of a sulfonyl chloride and pyridine |
| 02/05/2004 | WO2004011443A1 Pyrimidyl sulphone amide derivatives as chemokine receptor modulators |
| 02/05/2004 | WO2004011442A1 Pyrimidine derivatives |
| 02/05/2004 | WO2004011440A1 Antagonist of melanin-concentrating hormone receptor comprising benzimidazole derivative as active ingredint |
| 02/05/2004 | WO2004011438A1 Diaryl-substituted cyclic urea derivatives having an mch-modulatory effect |
| 02/05/2004 | WO2004011436A1 Quinoline derivatives and their use as mycobacterial inhibitors |
| 02/05/2004 | WO2004011431A1 Pleuromutilin derivatives as antimicrobbials |
| 02/05/2004 | WO2004011430A1 Sodium channel inhibitor |
| 02/05/2004 | WO2004011410A1 Chemical compounds |
| 02/05/2004 | WO2004011006A1 Use of a specific cyclic amine derivative or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure |
| 02/05/2004 | WO2004011001A1 Aqueous liquid preparations and light-stabilized aqueous liquid preparations |
| 02/05/2004 | WO2004010943A2 Substituted benzanilides as modulators of the ccr5 receptor |
| 02/05/2004 | WO2003089408A3 Optically active substituted pyridinylmethyl-sulphinyl-benzimidazole and salts |
| 02/05/2004 | WO2003080580A3 Quinoline derivatives and their use as 5-ht6 ligands |
| 02/05/2004 | WO2003074475A3 Substituted aryl ketones |
| 02/05/2004 | WO2003024386A3 Use of potent, selective and non toxic c-kit inhibitors for treating interstitial cystitis |